|
|
|
Insider
Information: |
Hbm Bioventures Cayman Ltd |
Relationship: |
10% Owner |
City: |
Grand Cayman |
State: |
E9 |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
12 |
|
Direct
Shares |
28,058,903 |
|
Indirect Shares
|
1,435,154 |
|
|
Direct
Value |
$303,328,335 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
29,494,057 |
|
|
Total
Value |
$303,328,335 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Icagen Inc |
ICGN |
10% Owner |
2005-02-08 |
1,200,000 |
2005-02-08 |
0 |
Premium* |
|
Harbor Brewing Company Inc |
HBWOD |
10% Owner |
2005-03-16 |
3,964,615 |
2005-03-16 |
1,435,154 |
Premium* |
|
Micrus Endovascular Corp |
MEND |
10% Owner |
2010-02-24 |
1,681,599 |
2005-06-21 |
0 |
Premium* |
|
Pacira Pharmaceuticals, Inc. |
PCRX |
10% Owner |
2013-03-25 |
2,233,993 |
|
0 |
Premium* |
|
PTC Therapeutics, Inc. |
PTCT |
10% Owner |
2013-12-17 |
2,441,504 |
2013-06-25 |
0 |
Premium* |
|
Iveric Bio Inc |
ISEE |
10% Owner |
2014-05-13 |
3,139,902 |
2013-09-30 |
0 |
Premium* |
|
Apollo Endosurgery, Inc |
APEN |
10% Owner |
2014-09-26 |
2,780,836 |
|
0 |
Premium* |
|
Paratek Pharmaceuticals Inc |
PRTK |
10% Owner |
2015-05-29 |
1,747,680 |
|
0 |
Premium* |
|
Nabriva Therapeutics AG |
NBRV |
10% Owner |
2017-09-14 |
2,334,128 |
|
0 |
Premium* |
|
Werewolf Therapeutics, Inc. |
HOWL |
10% Owner |
2021-05-04 |
625,995 |
2021-05-04 |
0 |
Premium* |
|
Io Biotech, Inc. |
IOBT |
10% Owner |
2021-11-09 |
2,690,545 |
2021-11-09 |
0 |
Premium* |
|
Mineralys Therapeutics, Inc. |
MLYS |
10% Owner |
2023-02-14 |
3,218,106 |
2023-02-14 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
104 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 5
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
NBRV |
Nabriva Therapeutics AG |
10% Owner |
|
2017-04-28 |
4 |
S |
$11.03 |
$166,813 |
D/D |
(15,130) |
2,593,962 |
0 |
- |
|
MEND |
Micrus Endovascular Corp |
10% Owner |
|
2007-08-21 |
4 |
S |
$23.10 |
$171,083 |
D/D |
(7,400) |
1,741,974 |
0 |
- |
|
MEND |
Micrus Endovascular Corp |
10% Owner |
|
2008-06-06 |
4 |
B |
$12.24 |
$183,725 |
D/D |
15,000 |
1,960,739 |
2.45 |
- |
|
NBRV |
Nabriva Therapeutics AG |
10% Owner |
|
2017-08-07 |
4 |
S |
$10.50 |
$186,795 |
D/D |
(17,790) |
2,373,387 |
0 |
- |
|
NBRV |
Nabriva Therapeutics AG |
10% Owner |
|
2017-09-13 |
4 |
S |
$8.54 |
$193,956 |
D/D |
(22,721) |
2,337,557 |
0 |
- |
|
NBRV |
Nabriva Therapeutics AG |
10% Owner |
|
2017-07-19 |
4 |
S |
$10.50 |
$218,253 |
D/D |
(20,786) |
2,421,367 |
0 |
- |
|
MEND |
Micrus Endovascular Corp |
10% Owner |
|
2009-08-10 |
4 |
S |
$11.00 |
$232,863 |
D/D |
(21,100) |
1,939,639 |
0 |
- |
|
MEND |
Micrus Endovascular Corp |
10% Owner |
|
2007-02-07 |
4 |
S |
$24.00 |
$234,144 |
D/D |
(9,756) |
1,810,244 |
0 |
- |
|
NBRV |
Nabriva Therapeutics AG |
10% Owner |
|
2017-04-07 |
4 |
S |
$10.96 |
$235,931 |
D/D |
(21,501) |
223,270 |
0 |
- |
|
NBRV |
Nabriva Therapeutics AG |
10% Owner |
|
2017-04-07 |
4/A |
S |
$10.96 |
$235,931 |
D/D |
(21,501) |
2,707,162 |
0 |
- |
|
MEND |
Micrus Endovascular Corp |
10% Owner |
|
2008-06-20 |
4 |
B |
$13.61 |
$244,072 |
D/D |
17,741 |
1,985,739 |
2.45 |
- |
|
MEND |
Micrus Endovascular Corp |
10% Owner |
|
2007-02-09 |
4 |
S |
$24.00 |
$245,856 |
D/D |
(10,244) |
1,800,000 |
0 |
- |
|
NBRV |
Nabriva Therapeutics AG |
10% Owner |
|
2017-07-20 |
4 |
S |
$10.50 |
$246,173 |
D/D |
(23,445) |
2,397,922 |
0 |
- |
|
PCRX |
Pacira Pharmaceuticals, I... |
10% Owner |
|
2013-03-19 |
4 |
AS |
$27.86 |
$253,501 |
D/D |
(9,100) |
2,524,893 |
0 |
- |
|
MEND |
Micrus Endovascular Corp |
10% Owner |
|
2009-08-07 |
4 |
S |
$10.80 |
$273,625 |
D/D |
(25,000) |
1,960,739 |
0 |
- |
|
PRTK |
Paratek Pharmaceuticals I... |
10% Owner |
|
2015-05-29 |
4 |
S |
$29.52 |
$297,908 |
D/D |
(10,000) |
1,747,680 |
0 |
- |
|
PCRX |
Pacira Pharmaceuticals, I... |
10% Owner |
|
2013-03-21 |
4 |
AS |
$27.50 |
$314,353 |
D/D |
(11,431) |
2,513,462 |
0 |
- |
|
MEND |
Micrus Endovascular Corp |
10% Owner |
|
2008-02-14 |
4 |
B |
$14.22 |
$325,943 |
D/D |
22,800 |
1,908,039 |
2.45 |
- |
|
MEND |
Micrus Endovascular Corp |
10% Owner |
|
2008-02-14 |
4 |
B |
$14.05 |
$333,648 |
D/D |
23,600 |
1,885,239 |
2.45 |
- |
|
PRTK |
Paratek Pharmaceuticals I... |
10% Owner |
|
2015-05-28 |
4 |
S |
$31.52 |
$334,985 |
D/D |
(10,580) |
1,757,680 |
0 |
- |
|
NBRV |
Nabriva Therapeutics AG |
10% Owner |
|
2017-04-06 |
4 |
S |
$11.20 |
$350,160 |
D/D |
(31,217) |
244,771 |
0 |
- |
|
NBRV |
Nabriva Therapeutics AG |
10% Owner |
|
2017-04-06 |
4/A |
S |
$11.20 |
$350,160 |
D/D |
(31,217) |
2,728,663 |
0 |
- |
|
MEND |
Micrus Endovascular Corp |
10% Owner |
|
2008-06-05 |
4 |
B |
$12.00 |
$361,699 |
D/D |
30,000 |
1,945,739 |
2.45 |
- |
|
NBRV |
Nabriva Therapeutics AG |
10% Owner |
|
2017-04-10 |
4/A |
S |
$10.73 |
$406,451 |
D/D |
(37,876) |
2,669,286 |
0 |
- |
|
NBRV |
Nabriva Therapeutics AG |
10% Owner |
|
2017-04-10 |
4 |
S |
$10.73 |
$406,451 |
D/D |
(37,876) |
185,394 |
0 |
- |
|
104 Records found
|
|
Page 3 of 5 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|